The food and drug administration (FDA)-cleared pediatric wearable devices market size has grown exponentially in recent years. It will grow from $0.61 billion in 2025 to $0.73 billion in 2026 at a compound annual growth rate (CAGR) of 20.1%. The growth in the historic period can be attributed to increasing prevalence of pediatric chronic diseases, rising demand for early diagnostic interventions, limited availability of child-specific medical wearables, growing hospital-based monitoring dependency, increasing awareness of preventive pediatric healthcare.
The food and drug administration (FDA)-cleared pediatric wearable devices market size is expected to see exponential growth in the next few years. It will grow to $1.52 billion by 2030 at a compound annual growth rate (CAGR) of 20.3%. The growth in the forecast period can be attributed to expansion of home-based pediatric healthcare monitoring, increasing adoption of ai-driven predictive health analytics, rising investment in pediatric digital health infrastructure, growing regulatory approvals for wearable medical devices, increasing integration of cloud and iot healthcare ecosystems. Major trends in the forecast period include rising adoption of ai-enabled pediatric wearable diagnostics for real-time health insights, increasing integration of iot-based connected monitoring ecosystems in pediatric care, expansion of cloud-based remote patient monitoring platforms for children, growing use of advanced biosensor miniaturization for improved wearable accuracy, increasing deployment of cybersecurity frameworks for pediatric health data protection.
The increasing prevalence of chronic pediatric conditions is expected to propel the growth of the FDA-cleared pediatric wearable devices market going forward. Chronic pediatric conditions refer to long-term health disorders affecting infants, children, or adolescents that typically persist for three months or more and often require continuous medical care, ongoing management, and in some cases, lifestyle modifications. Their rising incidence is being driven by multiple contributing factors, including environmental exposures, lifestyle shifts such as increased sedentary behavior and poor dietary habits, as well as enhanced diagnostic capabilities and greater awareness. FDA-cleared pediatric wearable devices, including continuous glucose monitoring systems and cardiac monitoring solutions, support real-time physiological tracking and early identification of complications, thereby enabling proactive disease management and improving treatment adherence. As the burden of chronic conditions continues to rise, healthcare systems, caregivers, and providers are increasingly adopting these technologies, which are supporting better patient outcomes while also helping to reduce long-term healthcare expenditures. For instance, in December 2025, according to the World Health Organization (WHO), a Switzerland-based United Nations (UN) organization, globally, an estimated 35 million children below five years of age were affected by excess weight in 2024, while more than 390 million individuals aged five to nineteen were overweight in 2022, including around 160 million with obesity. Therefore, the growing prevalence of chronic pediatric conditions is contributing to and propelling the growth of the FDA-cleared pediatric wearable devices market.
Leading companies operating in the FDA-cleared pediatric wearable devices market are focusing on innovative advancements such as therapeutic wearable devices to enable non-invasive, personalized treatment solutions. A therapeutic wearable device is a body-worn medical technology designed to deliver targeted therapeutic intervention directly to the user. For example, in June 2025, SoundHealth, a US-based medical technology company specializing in artificial intelligence-driven healthcare solutions, announced U. S. Food and Drug Administration (FDA) approval of SONU Band. The device utilizes artificial intelligence to map sinus structures and deliver customized acoustic vibrations that help reduce nasal inflammation and improve airflow. Its non-invasive, drug-free approach and at-home usability position it as a significant advancement in pediatric respiratory care by enhancing safety and treatment accessibility.
In February 2026, Natus Sensory, a US-based provider of sensory diagnostics, newborn care solutions, and clinical monitoring technologies, acquired TheraB Medical for an undisclosed amount. Through this acquisition, Natus Sensory aims to expand its newborn care portfolio by integrating wearable phototherapy technology, enhancing its therapeutic capabilities and enabling broader delivery of neonatal treatment across hospital and home-care settings. TheraB Medical is a US-based provider of wearable medical devices focused on neonatal jaundice treatment through innovative phototherapy solutions.
Major companies operating in the food and drug administration (fda)-cleared pediatric wearable devices market are Abbott Laboratories, Medtronic plc, Koninklijke Philips N. V., GE HealthCare Technologies Inc., Dexcom Inc., Masimo Corporation, Insulet Corporation, Nihon Kohden Corporation, iRhythm Technologies Inc., Natus Medical Incorporated, Bittium Corporation, Current Health Ltd., Sibel Health Inc., Empatica Inc., Owlet Baby Care Inc., LifeSignals Inc., VitalConnect Inc., Blue Spark Technologies Inc., BioIntelliSense Inc., Nonin Medical Inc., Biobeat Technologies Ltd., Lief Therapeutics Inc., Preventice Solutions Inc.
North America was the largest region in the food and drug administration (FDA)-cleared pediatric wearable devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the food and drug administration (FDA)-cleared pediatric wearable devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the food and drug administration (FDA)-cleared pediatric wearable devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The food and drug administration (FDA)-cleared pediatric wearable devices market consists of sales of products such as temperature monitoring patches, wearable electroencephalography monitoring systems, wearable blood pressure monitoring devices, hydration monitoring wearables, wearable seizure detection devices, posture monitoring wearables, and wearable movement and activity tracking devices for clinical use. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The food and drug administration (FDA)-cleared pediatric wearable devices market size is expected to see exponential growth in the next few years. It will grow to $1.52 billion by 2030 at a compound annual growth rate (CAGR) of 20.3%. The growth in the forecast period can be attributed to expansion of home-based pediatric healthcare monitoring, increasing adoption of ai-driven predictive health analytics, rising investment in pediatric digital health infrastructure, growing regulatory approvals for wearable medical devices, increasing integration of cloud and iot healthcare ecosystems. Major trends in the forecast period include rising adoption of ai-enabled pediatric wearable diagnostics for real-time health insights, increasing integration of iot-based connected monitoring ecosystems in pediatric care, expansion of cloud-based remote patient monitoring platforms for children, growing use of advanced biosensor miniaturization for improved wearable accuracy, increasing deployment of cybersecurity frameworks for pediatric health data protection.
The increasing prevalence of chronic pediatric conditions is expected to propel the growth of the FDA-cleared pediatric wearable devices market going forward. Chronic pediatric conditions refer to long-term health disorders affecting infants, children, or adolescents that typically persist for three months or more and often require continuous medical care, ongoing management, and in some cases, lifestyle modifications. Their rising incidence is being driven by multiple contributing factors, including environmental exposures, lifestyle shifts such as increased sedentary behavior and poor dietary habits, as well as enhanced diagnostic capabilities and greater awareness. FDA-cleared pediatric wearable devices, including continuous glucose monitoring systems and cardiac monitoring solutions, support real-time physiological tracking and early identification of complications, thereby enabling proactive disease management and improving treatment adherence. As the burden of chronic conditions continues to rise, healthcare systems, caregivers, and providers are increasingly adopting these technologies, which are supporting better patient outcomes while also helping to reduce long-term healthcare expenditures. For instance, in December 2025, according to the World Health Organization (WHO), a Switzerland-based United Nations (UN) organization, globally, an estimated 35 million children below five years of age were affected by excess weight in 2024, while more than 390 million individuals aged five to nineteen were overweight in 2022, including around 160 million with obesity. Therefore, the growing prevalence of chronic pediatric conditions is contributing to and propelling the growth of the FDA-cleared pediatric wearable devices market.
Leading companies operating in the FDA-cleared pediatric wearable devices market are focusing on innovative advancements such as therapeutic wearable devices to enable non-invasive, personalized treatment solutions. A therapeutic wearable device is a body-worn medical technology designed to deliver targeted therapeutic intervention directly to the user. For example, in June 2025, SoundHealth, a US-based medical technology company specializing in artificial intelligence-driven healthcare solutions, announced U. S. Food and Drug Administration (FDA) approval of SONU Band. The device utilizes artificial intelligence to map sinus structures and deliver customized acoustic vibrations that help reduce nasal inflammation and improve airflow. Its non-invasive, drug-free approach and at-home usability position it as a significant advancement in pediatric respiratory care by enhancing safety and treatment accessibility.
In February 2026, Natus Sensory, a US-based provider of sensory diagnostics, newborn care solutions, and clinical monitoring technologies, acquired TheraB Medical for an undisclosed amount. Through this acquisition, Natus Sensory aims to expand its newborn care portfolio by integrating wearable phototherapy technology, enhancing its therapeutic capabilities and enabling broader delivery of neonatal treatment across hospital and home-care settings. TheraB Medical is a US-based provider of wearable medical devices focused on neonatal jaundice treatment through innovative phototherapy solutions.
Major companies operating in the food and drug administration (fda)-cleared pediatric wearable devices market are Abbott Laboratories, Medtronic plc, Koninklijke Philips N. V., GE HealthCare Technologies Inc., Dexcom Inc., Masimo Corporation, Insulet Corporation, Nihon Kohden Corporation, iRhythm Technologies Inc., Natus Medical Incorporated, Bittium Corporation, Current Health Ltd., Sibel Health Inc., Empatica Inc., Owlet Baby Care Inc., LifeSignals Inc., VitalConnect Inc., Blue Spark Technologies Inc., BioIntelliSense Inc., Nonin Medical Inc., Biobeat Technologies Ltd., Lief Therapeutics Inc., Preventice Solutions Inc.
North America was the largest region in the food and drug administration (FDA)-cleared pediatric wearable devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the food and drug administration (FDA)-cleared pediatric wearable devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the food and drug administration (FDA)-cleared pediatric wearable devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The food and drug administration (FDA)-cleared pediatric wearable devices market consists of sales of products such as temperature monitoring patches, wearable electroencephalography monitoring systems, wearable blood pressure monitoring devices, hydration monitoring wearables, wearable seizure detection devices, posture monitoring wearables, and wearable movement and activity tracking devices for clinical use. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market Characteristics
3. Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market Supply Chain Analysis
4. Global Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market Trends and Strategies
5. Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market Analysis of End Use Industries
7. Global Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Total Addressable Market (TAM) Analysis for the Market
9. Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market Segmentation
10. Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market Regional and Country Analysis
11. Asia-Pacific Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market
12. China Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market
13. India Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market
14. Japan Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market
15. Australia Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market
16. Indonesia Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market
17. South Korea Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market
18. Taiwan Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market
19. South East Asia Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market
20. Western Europe Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market
21. UK Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market
22. Germany Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market
23. France Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market
24. Italy Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market
25. Spain Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market
26. Eastern Europe Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market
27. Russia Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market
28. North America Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market
29. USA Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market
30. Canada Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market
31. South America Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market
32. Brazil Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market
33. Middle East Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market
34. Africa Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market
36. Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market Competitive Landscape and Company Profiles
37. Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market Other Major and Innovative Companies
41. Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market High Potential Countries, Segments and Strategies
42. Appendix
Executive Summary
Food And Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses food and drug administration (fda)-cleared pediatric wearable devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for food and drug administration (fda)-cleared pediatric wearable devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The food and drug administration (fda)-cleared pediatric wearable devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Device Type: Pulse Oximeters; Cardiac Monitors Or Electrocardiogram Wearables; Respiratory Monitors; Multi-Vital Monitors; Glucose Monitoring Wearables; Sleep Trackers2) By Clinical Use: Cardiac Monitoring; Respiratory Monitoring; Glucose Monitoring; Temperature Monitoring; Sudden Infant Death Syndrome Adjunct Monitoring
3) By Technology: Optical (Photoplethysmography); Electrical (Electrocardiography); Accelerometers; Bio-Impedance
4) By End-User: Hospitals And Neonatal Intensive Care Units; Pediatric Clinics And Outpatient Centers; Homecare Settings And Caregivers; Ambulatory Surgical Centers
Subsegments:
1) By Pulse Oximeters: Fingertip Pulse Oximeters; Wrist-Worn Pulse Oximeters; Handheld Pulse Oximeters; Ring-Based Pulse Oximeters2) By Cardiac Monitors Or Electrocardiogram Wearables: Patch-Based Cardiac Monitors; Chest Strap Heart Monitors; Wearable Holter Monitors; Smart Garment Cardiac Monitors
3) By Respiratory Monitors: Wearable Respiratory Rate Monitors; Chest-Worn Breathing Monitors; Apnea Monitoring Devices; Smart Garment Respiratory Monitors
4) By Multi-Vital Monitors: Integrated Vital Sign Monitoring Wearables; Smart Patch Multi-Vital Monitors; Wrist-Worn Multi-Parameter Monitors; Smart Clothing Multi-Vital Monitors
5) By Glucose Monitoring Wearables: Continuous Glucose Monitoring Devices; Flash Glucose Monitoring Devices; Implantable Glucose Monitoring Devices; Non-Invasive Glucose Monitoring Wearables
6) By Sleep Trackers: Wearable Sleep Monitoring Bands; Smart Sock Sleep Trackers; Mattress-Integrated Sleep Monitoring Devices; Smart Pajamas And Sleep Garment Trackers; Wrist-Worn Pediatric Sleep Trackers; Sleep And Movement Monitoring Patches; Infant Sleep Position Monitors; Multi-Parameter Sleep Tracking Wearables
Companies Mentioned: Abbott Laboratories; Medtronic plc; Koninklijke Philips N.V.; GE HealthCare Technologies Inc.; Dexcom Inc.; Masimo Corporation; Insulet Corporation; Nihon Kohden Corporation; iRhythm Technologies Inc.; Natus Medical Incorporated; Bittium Corporation; Current Health Ltd.; Sibel Health Inc.; Empatica Inc.; Owlet Baby Care Inc.; LifeSignals Inc.; VitalConnect Inc.; Blue Spark Technologies Inc.; BioIntelliSense Inc.; Nonin Medical Inc.; Biobeat Technologies Ltd.; Lief Therapeutics Inc.; Preventice Solutions Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Food and Drug Administration (FDA)-Cleared Pediatric Wearable Devices market report include:- Abbott Laboratories
- Medtronic plc
- Koninklijke Philips N.V.
- GE HealthCare Technologies Inc.
- Dexcom Inc.
- Masimo Corporation
- Insulet Corporation
- Nihon Kohden Corporation
- iRhythm Technologies Inc.
- Natus Medical Incorporated
- Bittium Corporation
- Current Health Ltd.
- Sibel Health Inc.
- Empatica Inc.
- Owlet Baby Care Inc.
- LifeSignals Inc.
- VitalConnect Inc.
- Blue Spark Technologies Inc.
- BioIntelliSense Inc.
- Nonin Medical Inc.
- Biobeat Technologies Ltd.
- Lief Therapeutics Inc.
- Preventice Solutions Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | July 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 0.73 Billion |
| Forecasted Market Value ( USD | $ 1.52 Billion |
| Compound Annual Growth Rate | 20.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
